Insider Trading activities at Aligos Therapeutics, Inc. (ALGS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aligos Therapeutics, Inc. (ALGS) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aligos Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1799448.

Total stock buying since 2020: $23,255,735.
Total stock sales since 2020: $0.
Total stock option exercises since 2020: $0.


5 insiders reported insider trading activities at Aligos Therapeutics, Inc. (ALGS):
Insider trading activities of Woiwode Thomas
Insider trading activities of Versant Vantage I, L.p.
Insider trading activities of Nuechterlein Carole
Insider trading activities of Vivo Capital Surplus Fund Viii, L.p.
Insider trading activities of Novo Holdings A/s

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Aligos Therapeutics, Inc. (ALGS).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 7,933,601 $6,005,735 0 $0 0 $0
2020 1,150,000 $17,250,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Aligos Therapeutics, Inc. (ALGS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-10 7,933,601 $6,005,735 0 $0 0 $0
2020-10 1,150,000 $17,250,000 0 $0 0 $0

Table 3. Detailed insider trading at Aligos Therapeutics, Inc. (ALGS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-10-25 Nuechterlein Carole Buy 7,933,601 .76 6,005,735
2020-10-20 Versant Vantage I, L.p. Buy 200,000 15.00 3,000,000
2020-10-20 Vivo Capital Surplus Fund Viii, L.p. Buy 550,000 15.00 8,250,000
2020-10-20 Woiwode Thomas Buy 200,000 15.00 3,000,000
2020-10-20 Novo Holdings A/s (10% Owner) Buy 200,000 15.00 3,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of ALGS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aligos Therapeutics, Inc. (symbol ALGS, CIK number 1799448) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.